A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition:   Edema Due to Heart Failure or Cirrhosis Intervention:   Drug: Spironolactone Oral Suspension Sponsor:   CMP Development, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions:   Cardiotoxicity;   Neoplasms;   Chemotherapy Effect;   Heart Failure Interventions:   Drug: Spironolactone;   Drug: Placebo Sponsor:   University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions:   Alcohol Use Disorder;   Hiv Intervention:   Drug: Spironolactone Sponsors:   Yale University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials